A new era, where AI is at the centre of the drug discovery process is emerging, says Charlotte Deane, a professor of ...

Eli Lilly’s idiopathic pulmonary fibrosis deal with Mediar is centered around MTX-463, an anti-WISP1 antibody that early ...

Scotland has the highest rate of drugs deaths in Europe, with fatalities rising by 12 in a year to 1,172 drug-related deaths in 2023.

A consortium including scientists from the Tropical Institute at LMU University Hospital has demonstrated the effectiveness ...

A Winnipeg woman who trained as a doctor in the Philippines says she doesn't trust the Manitoba health care system after ...

Boston-area startup Mediar Therapeutics is teaming up with Eli Lilly on a new drug for idiopathic pulmonary fibrosis. Lilly — one of the five large pharmas backing Mediar – will pay ...

When a cold strikes, you want fast, effective relief. And while grabbing the first over-the-counter cold medication seems ...

The integration of artificial intelligence (AI) into healthcare has opened new frontiers for improving patient care and ...

Esther Rajavelu Appointed Interim President and Chief Executive Officer, Frank Thomas Appointed Chairman of the Board Interim Changes to Leadership Follow the Company's Response to a Wells Notice from ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...